| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-07 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |